Roundup trial: Monsanto lawyers grill expert witness for omitting key details around alleged glyphosate-cancer link

roundup spray

Lawyers for Monsanto attempted on [July 20th] to undermine a Chicago oncologist’s opinion that its Roundup weed killer caused a Bay Area man’s terminal lymphoma, saying he omitted important details in his trial testimony proving the herbicide wasn’t the culprit.

Monsanto lawyer George Lombardi with Winston & Strawn flagged three instances in which Cardinal Health oncologist Chadi Nabhan failed to identify references in plaintiff DeWayne Johnson’s medical records to the first symptoms of his disease, apparently showing Johnson had been exposed to Roundup for a little over a year before developing symptoms instead of the two years his lawyers claim.

Key to the case is how long it takes cancer symptoms to manifest after exposure to a cancer-causing agent. Monsanto says it takes 20 years, eliminating Roundup as the cause of Johnson’s disease. But Nabhan said [July 20th] it can take less time.

…

Nabhan, who is not Johnson’s doctor but examined him and reviewed his medical records late last year, testified that Johnson’s high exposure to Roundup over a two-year period was a “substantial contributing factor” in the development of his disease, noting that Johnson sprayed it four times a week, every week during the summer months and for several hours each day.

But on cross-examination, Lombardi pointed to medical records Nabhan omitted from his earlier testimony indicating Johnson had a rash in September and December 2013, an early symptom of non-Hodgkin lymphoma.

The records also showed Johnson was diagnosed in early 2014 with T-cell lymphoma, though not specifically with mycosis fungoides, Lombardi said. That more-specific diagnosis came later that year.

Read full, original article: Monsanto Lawyers Question Cancer Expert in Roundup Trial

No longer a fringe theory? Herpes virus can spark ‘cascade of events’ leading to Alzheimer’s

alzheimers

For decades, the idea that a bacteria or virus could help cause Alzheimer’s disease was dismissed as a fringe theory. But not so much anymore. On [July 11], a team of researchers from Harvard Medical School reported in the journal Neuron the latest bit of evidence suggesting herpesviruses can spark the cascade of events that leads to Alzheimer’s disease, a fatal form of dementia that afflicts at least 5 million Americans.

The researchers studied how neurons in mice responded to the presence of herpes simplex 1 (HSV-1), the virus that causes cold sores. In a separate experiment involving a 3D model of the human brain grown in a dish, they also studied human herpesvirus 6 (HHV-6), the germ responsible for causing the childhood skin disease roseola.

…

In the current study, both viruses seemed to provoke an identical reaction. The mice’s brains grew new deposits of amyloid-β plaques practically “overnight,” according to senior author Rudy Tanzi, a geneticist.

…

Viruses are only one of the things that could set off Alzheimer’s, he pointed out. The same sort of seeding might happen in people whose genes cause them to make too much amyloid-β, in the absence of infection. And genetics might help explain why only some people’s infections cause the brain to start producing amyloid-β en masse. “Just having the virus isn’t enough,” Tanzi said.

Read full, original post: Yet More Evidence that Viruses May Cause Alzheimer’s Disease

As fears of ‘rogue’ GMO wheat ease, Japan lifts ban on Canadian imports

gmo wheat

One day [in] July [2017], a contractor noticed a few stalks of wheat growing by the side of an access road in southern Alberta survived being sprayed with Roundup, a powerful herbicide. By virtue of their hardiness they soon ended up in a government lab, and eventually led the Japanese government to impose a sweeping ban on the import of Canadian wheat, one it finally lifted on [July 20th]. But even as farmers celebrate the news, the rogue wheat’s resilience has created a lingering agricultural mystery, one for which no solution is in sight.

…

Each year, Japan imports between 1.5 and 1.7 million tonnes of Canadian wheat, said Cam Dahl, president of agriculture industry non-profit Cereals Canada Inc. With Indonesia, Japan vies for the title of second-largest importer of Canadian wheat, after the U.S. And the Japanese, Dahl said, “are premium buyers, so they buy the highest quality of any customer.”

…

According to Dahl, Japan tested hundreds of thousands of tonnes of Canadian wheat already in the country for any sign of genetic modification. Among Canadian producers, there were concerns that some shipments already en route to the country would have to divert when the ban was announced, but Dahl said they were allowed to unload, and then were tested while in storage. Those tests found none of the genetically modified wheat, and so on [July 20th] Japan lifted its ban, though it will continue to test imported Canadian wheat for modification.

Read full, original article: Japan drops ban on Canadian wheat, but mystery over genetically modified samples lingers

Turning white blood cells into ‘living cancer drugs’ with electric shocks

cells x

A promising new class of cancer treatments recruits the cells in our blood to fight tumors, using powerful gene-editing tools to transform a type of white blood cell — called a T cell — from an immune cell that normally targets bacterial or fungal infections into a living cancer drug.

The genetic alterations could boost immune systems to successfully fight cancers on their own. Researchers remove T cells from patients and slip new genes into the cells. After clinicians return the modified T cells to patients, the cells, like microscopic bloodhounds, lead the immune system on the hunt for tumors.

…

Disabled viruses, which inject genes into cells like a shot from a syringe, are the current standard.

…

[Immunologist Alexander] Marson and his colleagues have developed a new, faster method to reprogram T cells, as they described [July 11] in the journal Nature. Rather than relying on viruses to deliver the genetic package, researchers jolted T cells with electricity. The shock relaxed the membranes that surround the cells, making them receptive to new genetic material.

…

“It’s a turning point,” said Vincenzo Cerundolo, director of the Human Immunology Unit at Oxford University.

…

He predicts cheaper therapies and much faster development times — as swiftly as a week, rather than the months required to manufacture a virus.

Read full, original post: With new genes and an electric shock, scientists turn immune cells against cancer

CRISPR-edited seeds ‘personalized’ for individual farms could boost worldwide food production

GeneEditcrispr x

The seeds farmers plant in their fields can carry certain desirable traits, such as drought tolerance or pest resistance. Breeding or genetic engineering can produce such traits, but ag biotech startup Inari Agriculture aims to take trait development to a new level—customizing seeds to grow best in the soil and weather at the farm where they’ll be planted.

Cambridge, MA-based Inari is emerging from stealth…to allow a peek at its technology and its plans. CEO Ponsi Trivisvavet…says Inari has developed a way to optimize seeds to fit local conditions, such as the humidity, the day and night-time temperatures, and even the soil type of a farm. She says the company, founded in 2016, aims to bring its “personalized seed for farmers” into field testing by [2019’s] growing season.

…

Wheat, soybean, and corn will be the company’s first targets. The time savings will come from the use of computational agronomy and gene-editing techniques; cost savings will come from the reduced need for fertilizers and other crop inputs, Trivisvavet says. She adds that the Inari seeds should produce higher yields, and enable farmers to grow a higher-value crop. For example, the technology can develop wheat varieties that have higher protein content, which would allow farmers to sell their wheat as a premium product.

…

If all goes well in field trials, Trivisvavet says that the Inari technology [will be used] to develop customized seeds that can be sold to growers in the U.S., and eventually, the rest of the world.

Read full, original article: Inari Agriculture Sprouts with Plans to Gene Edit “Personalized Seeds”

‘Evolution is aimless’: How else do we explain external testicles?

evolution species natural selection

Evolution is a work in progress, so it’s hardly surprising that some of the features it has built into the human body are still far from optimal. And of all those features, one of the hardest to explain is also one of the most conspicuous: external testicles.

From an evolutionary standpoint, after all, testicles are the most important thing about a man — without them, he wouldn’t exist at all. And there they are, just sitting out in the open. Exposed. Vulnerable. What kind of design is this?

Of course, there is an explanation. Human sperm cells develop better at a slightly lower temperature than the rest of our body seems to prefer. Humans aren’t alone in this respect: Most male mammals have testicles that migrate through the inguinal canal during gestation or infancy and eventually take up residence outside the abdominal cavity, suspended in a temperature-sensitive adjustable hammock. This allows the sperm cells to develop at the temperature that’s just right.

But is it really just right? Only if you accept that the ideal temperature is a special fixed property of the universe, like Planck’s constant or the speed of light in a vacuum. Evolution could have simply tweaked the parameters of sperm development so the ideal temperature of its enzymatic and cellular processes was the same as the rest of the body’s processes. Hematopoiesis, the creation of new blood cells, is a close parallel of sperm development in terms of the tissue architecture and cellular events involved, yet bone marrow doesn’t grow outside our body. Nor do ovaries, for that matter.

undark logoThe fact is that there is no good reason that sperm development has to work best at lower temperatures. It’s just a fluke, an example of poor design. If nature had an intelligent designer, he or she would have a lot to answer for. But since natural selection and other evolutionary forces are the true designers of our bodies, there is no one to question about this. We must interrogate ourselves: Why are we like this?

The so-called “argument from poor design” goes back to Darwin himself. Prior to evolutionary theory, most people, scientists included, considered the world and everything in it to be the flawless creation of a perfect God. Of course, the rampant imperfections we can all easily spot called out for explanation and usually invoked a response along the lines of a “fall from grace” or some other such hand-waving. Now that we know that evolution is the creative force of life, we can be free from the expectation of perfection.

But we’re not. Far too often we repeat refrains like “Well, it must do something important or natural selection would have eliminated it,” or “Living things are perfectly suited for their habitats,” or “Evolution doesn’t tolerate inefficiency.” We haven’t really moved on from the creationist mindset that expects to see perfection in nature.

The reality is that evolution is aimless, natural selection is clumsy, and there’s no such thing as being perfectly adapted. Our bodies are a mishmash of compromises forged in different eras and by survival forces very different from the ones we now face. Evolution can work only with the bodies that we have, as they are, and can achieve “progress” only through the slightest tweaks and tugs. Even more frustrating, the selective forces themselves are constantly changing due to the dynamic nature of environments and ecosystems.

External testicles are just such an example. There are competing theories on how this strange quirk came about. Perhaps the testicles were escaping the newly warming abdomen of early mammals. There are other, more esoteric hypotheses as well, none of them perfectly satisfying, all of them potentially contributing a kernel of truth. In the end, it doesn’t really make sense, but, well, there they are.

Mis- and disinformation are distorting science and public policy. Subscribe to our Daily and Weekly Digests for incisive coverage of ‘disruptive’ innovations in AI, agricultural biotechnology, food, chemicals, nuclear energy, vaccines, and other disruptive innovations.

In addition to the obvious danger of designing such important organs without any protection or even padding, external testicles introduce additional problems for mammals. One in four men will develop a hernia in their groin, 10 times the rate of women, precisely because of a weakness in the abdominal wall left from the migration of the testicles out of the abdomen. Surgical repair is relatively straightforward, but surgery is a relatively new invention in the history of our species. While only a small percentage of these hernias become life-threatening, given how common they are, hernias have killed untold millions over the ages.

The interesting evolutionary questions don’t end with the origin of external testicles. How they got there is one question; what has happened since they got there is another, and we can actually get some answers to that question. While lots of physical variation is selectively neutral, there is reason to believe that conspicuous testicles served additional purposes for their bearers. Perhaps there was a sexual selective advantage in advertising testicles prominently, especially in creatures for whom sperm competition is important. If you got ’em, flaunt ’em.

chimps 6 5 18While humans have relatively modest testicles, our closest relatives, the chimpanzees, harbor comparatively enormous ones, around three times the size of ours even though our overall body weight is similar. What does this tell us? Perhaps the large testicles indicate that male chimpanzees engage in sperm competition, in which the males who create and deposit the most sperm are rewarded with the most offspring. But sperm competition would exist only if the chimps, particularly the females, have sex with multiple partners. In a monogamous arrangement, there would be no advantage in having big testicles and lots of sperm.

And biologists have noticed that when choosing male sexual partners, female chimps prefer those with large testicles. Why? If we assume that testicle size is at least partially controlled by genetics, the female’s reproductive choices influence the traits of the children she will bear, including their genitals. If she chooses a mate with big balls, her sons will have big balls, and if big balls help him have more offspring, she’ll get more grandchildren. It is therefore in her reproductive interest to pursue attractive mates, because they’ll lead to attractive children, and that will boost her genetic legacy. This is known as the “sexy son” hypothesis.

Of course, human testicles are just one glaring example of the quirks that demonstrate how imperfect evolution can be. No sane engineer would design a body with such a bent back, weak knees, and nasal sinuses that have to drain upward. We fail at synthesizing basic vitamins, our immune cells frequently attack our own bodies, and our DNA is mostly gobbledygook. This is not good design.

While the flaws themselves demonstrate the random, haphazard way that evolution works, even more interesting are the backstories of each flaw. We don’t make vitamin C because a primate ancestor already had plenty of it served up right there in its environment. Our sinuses are a mess because evolution smooshed the snouts of monkeys into a more flattened face than other mammals — and then, for reasons we don’t fully understand, humans developed still flatter and smaller faces.

These are not simply obscure academic issues. Our inability to make vitamin C caused the death of millions of our forebears from scurvy. Poor drainage in our meandering sinuses causes frequent and painful infections. We are evolved to survive and reproduce, but not necessarily to be healthy, comfortable, or happy.

Even our powerful minds, supposedly our crowning achievement, are anything but perfect. The biggest threats we now face are purely of our making. Because evolution does not make long-term plans, neither do we: We jump to conclusions, think only of the short term, ignore evidence we don’t like, and fear and despise those who are different from us. And unlike external testicles, which are merely inconvenient, these are flaws that could one day prove fatal to our imperfect species.

Nathan H. Lents is professor of biology and director of the Macaulay Honors College at John Jay College, part of the City University of New York. He maintains the Human Evolution Blog, writes for Psychology Today, and hosts the podcast “This World of Humans.” Besides his new book, he is the author of “Not So Different: Finding Human Nature in Animals.” Follow him on Twitter @nathanlents 

This article was originally published on Undark as Evolution’s Worst Mistake? How About External Testicles? and has been republished here with permission.

Talking Biotech: The story of a vitamin-infused sweet potato that helped cut Africa’s infant mortality 25 percent

Children eating OFSP in Munguini

The 2016 World Food Prize went to a group that coordinated the breeding, promotion and distribution of the orange-fleshed sweet potato in Africa. One of [the researchers] on the team was economist Dr. Jan Low. The sweet potato grows well in many parts of Africa. It is not the sweet potato known to westerners. It is white and dry, and more like bread than the well known Thanksgiving sweet potato.

At the same time there is widespread vitamin A deficiency, especially among children. Could the orange sweet potato help solve a critical micronutrient deficiency? Dr. Low and her team introduced the orange fleshed sweet potato to Africa, breeding them against locally adapted varieties. The new potatoes were introduced with marketing campaigns, helping introduce new populations to this novel product. Soon, the orange fleshed sweet potato was aiding the diet, saving lives, and creating new entrepreneurial opportunities for African farmers and commerce.

Follow Jan: @JanLow1 and visit her website.

Visit the Talking Biotech website

Follow Talking Biotech on Twitter @TalkingBiotech

Follow Kevin Folta on Twitter @kevinfolta | Facebook: Facebook.com/kmfolta/ | Lab website: Arabidopsisthaliana.com | All funding: Kevinfolta.com/transparency

Follow Paul Vincelli on Twitter @Pvincell | University of Kentucky webpage 

‘No reason to panic’: Experts react to study suggesting CRISPR isn’t as precise as we thought

crispr

A new study, published in Nature Biotechnology, investigates the use of CRISPR/Cas9 to make simple cuts in DNA in mouse cells and subsequent on-target mutagenesis due to the inaccuracy of the type of DNA repair process employed. [The study suggests that CRISPR may not be as precise as previously thought.]

Dr Helen O’Neill, Programme Director, Reproductive Science and Women’s Health, University College London, said:

…

“Of course, when assessing a new technology like this, a multitude of variables need to be accounted for; cell type, the intended DNA cut, the guides used to locate this genomic cutting site and, quite importantly, the choice of molecular scissors, of which there are many. Cas9 was the chosen molecular scissors in this study and while different cell types were analysed, the genetic architecture of cells in vitro (in a dish), will never truly reflect their behaviour in a body (in vivo).

…

“It is well understood that sufficient sequencing would take place prior to the introduction of this technology clinically, but this paper should encourage researchers to thoroughly analyse their intended editing.”

Dr Christophe Galichet, Senior Laboratory Research Scientist at The Francis Crick Institute, said:

“The data produced in the paper are very sound and well supported.  However, one can wonder how the type of mutations describe in the paper, some of which being large deletions, were missed in previous studies…Previous studies have analysed the extent of unwanted mutations when using Crispr/Cas, using whole genome sequencing or other methods, and did not find evidence of off-target mutation or large DNA deletions/ insertions.

…

“The paper does not remove the validity of the use of Crispr in clinical and non-clinical studies. A greater understanding of the Crispr/Cas9 system outcomes will lead to a safer use, as we will know what to expect. In non-clinical studies, where research animals are used, specific genetic mutations are selected for and thus deletion/insertion/chromosomal rearrangement which could be misread as wildtype allele, like described in the paper, will be discarded.”

Prof Robin Lovell-Badge FMedSci FRS, Group Leader, The Francis Crick Institute, said:

“It is hard to know whether the few results in this short paper are significant or not. The authors claim that they find unsuspected DNA damage associated with the use of “CRISPR” genome editing (Cas9 and gRNAs). This has been seen before, albeit rarely, and is obviously something that would need to be checked in any clinical application of the methods. The authors suggest that these alterations in DNA, which tend to be at or close to the target site, occur at much higher levels than anticipated. The paper is technically very sound – indeed the work is of high quality. However, it is not at all clear that the specific protocols used in the paper would relate much to any sensible use of genome editing clinically.

…

“In conclusion, this paper highlights the need when conducting experiments involving genome editing, and particularly for clinical applications, to verify that the alterations to the DNA sequence are those, and only those, that had been designed to occur. This has always been obvious. But the results give no reason to panic or to lose faith in the methods when they are carried out by those who know what they are doing.”

Dr Francesca Forzano, Consultant in Clinical Genetics and Genomics, Guy’s & St Thomas’ NHS Foundation Trust, said:

“This important work demonstrates that this technique is much less safe than previously thought, and suggests that the techniques previously used to monitor the efficiency and safety of CRISPR/Cas9 exploitation were not entirely adequate.

…

“This is a good quality research piece. Results fit to the existing evidence and brings new data and robust evidence regarding a collateral damage of this technique. The data will have a great impact in this field, as it suggests different techniques for monitoring on and off site effects should be used. They also demonstrate that this technique can be less safe than previously anticipated. Researchers should take this work into account when looking into clinical applications using this technique.”

Dr Lydia Teboul, Head of Molecular and Cellular Biology at the Mary Lyon Centre, MRC Harwell Institute, said:

“This is the recognition that we still have to learn a lot about the system (which has only been used for a few years) and just as importantly about the way cells repair cuts in their DNA. The technology still holds great promises for our developing therapeutic strategies that involve making genetic changes in cells and tissues. With these important studies we are learning about the precautions that we will need to take as we use the powerful genome editing tools for therapy.”

Read full, original post: Expert reaction to study looking at deletions and rearrangements due to the CRISPR/Cas9 genome editing technique 

Organic industry splinters as USDA ‘bioengineered’ labeling initiative progresses

Screen Shot at PM

Richmond-based Nature’s Path Foods, a leading organic breakfast company in North America, has recently announced its resignation from the Organic Trade Association (OTA), citing concerns that “the association is moving towards a non-organic agenda and away from its commitment to supporting the organic food movement.”

According to Nature’s Path, a couple of recent actions taken by the OTA have driven this decision, including supporting a “vague and misleading” national genetically modified organism (GMO) labelling law in the U.S., and allowing hydroponics to fall under the organic certification label, which the company believes has no organic agriculture or soil present.

…

The company believes that the new GMO labelling law in the U.S. could exclude almost three-fourths of products with genetically engineered ingredients and use confusing new GMO terminology and symbols for on-pack disclosures.

…

“Our departure from the OTA is an act of protest to raise awareness about our concerns that the important role organic plays to support the health of consumers and our planet is being compromised,” said Arran Stephens, Nature’s Path founder and co-CEO, in a press release.

“We believe giant food corporations, who also happen to own small organic brands, use the OTA to influence policy decisions to protect the best interests of their large, non-organic food portfolios.”

Read full, original article: Nature’s Path resigns from Organic Trade Association in protest of U.S. GMO law

Live to 150? AI suggests it’s possible, but not without clearing huge ‘hurdles’

ef c b o
[Scientist Alex Zhavoronkov] firmly believes that aging research is the most important field of science right now. In the past, Zhavoronkov claimed that he expected to live to be 150, but now he’s more conservative. He’s skeptical that we will see such drastic changes to the human lifespan quite so soon. There are too many hurdles left to clear, and he feels that today’s political and economic climate isn’t exactly conducive to expensive, experimental longevity research. To be clear, he does believe humanity will someday live that long, but not as soon as he thought

…

[Zhavoronkov’s team] have developed artificially-intelligent algorithms that can conceptualize and design new molecules to use in longevity-boosting treatments. They’ve also built AI systems that can pore over huge sets of real-world data to come up with personalized recommendations and tools for people who want to maximize their time above the dirt.

…

Zhavoronkov’s team also recently published a paper that uses a machine learning algorithm to precisely track how our muscles change as we age, connecting the aging process to specific genes. Developing ways to measure aging helps Zhavoronkov and his team understand how our bodies change over time and, eventually, what we might be able to do about it.

…

In an ideal world, transformative changes will ripple through healthcare within ten to fifteen years, Zhavoronkov predicts.

Read full, original post: This Scientist Predicted He Would Live to 150. Now He’s Not So Sure

Viewpoint: CRISPR-edited tomatoes illustrate our newfound power to ‘transform our food’

cfd e fca c d fc b a a e cf a be a b d tomaat genome editing bc c e x ccc x

LIKE ANY SELF-RESPECTING farmer, Zachary Lippman was grumbling about the weather. Stout, with close-cropped hair and beard, Lippman was standing in a greenhouse in the middle of Long Island, surrounded by a profusion of rambunctiously bushy plants. “Don’t get me started,” he said, referring to the late and inclement spring.

…

ALTHOUGH HE WORKED on a farm as a teenager and has a romantic attachment to the soil, ­Lippman isn’t a farmer. He’s a plant biologist at Cold Spring Harbor Laboratory in New York with an expertise in genetics and development. And these greenhouse plants aren’t ordinary tomatoes.

…

What makes this greenhouse different—what makes it arguably an epicenter of a revolution in plant biology that may forever change not just the future of the tomato but the future of many crops—is that 90 percent of the tomato plants in the building had been genetically altered using the wizardly new gene-editing tool known as Crispr/Cas-9.

…

Huge questions vex the future of food—how to feed 9 billion mouths, how to farm in an era of unprecedented climate uncertainty, how to create more resilient and nutritious foods for a public wary of the new technology. Plant scientists are already using Crispr and related technologies to reshape food crops in dramatic ways…

…

In both industrial and academic labs, new editing tools are being developed that will have a profound impact on the foods all of us eat.

Read full, original article: Crispr Can Speed Up Nature—and Change How We Grow Food (Paywall after two free articles)

Can we slow cancer through the power of positive thinking?

eae a z

From savoring a piece of cake to hugging a friend, many of life’s pleasures trigger a similar reaction in the brain—a surge of chemicals that tell the body “that was good, do it again.” Research published [July 13] in Nature Communications suggests this feel-good circuit may do much more.

Using lab tools to activate that reward circuit in mice, scientists discovered that its chemical signals reach the immune system, empowering a subset of bone marrow cells to slow the growth of tumors. The findings have yet to be confirmed in humans. But given the reward system is linked with positive emotions, the research offers a physiological mechanism for how a person’s psychological state could help to stall cancer progression.

…

[R]esearchers in Israel turned the mind-body question into an easier-to-measure physiological one: Would activation of the reward circuit have any effect on the immune system?

…

In mice with implanted cancer cells, two weeks of daily reward circuit stimulation produced a powerful response—their tumors were 40 to 50 percent smaller than those in control mice that didn’t get the brain activation.

…

[T]he new mouse findings do not suggest cancer patients should quit taking medication and rely instead on positive thinking. They merely offer a possible mechanism for the latter’s purported benefits.

Read full, original post: Could Brain Stimulation Slow Cancer?

Viewpoint: GMOs may be controversial, but bio-technology is creating a greener, cleaner world

QuimicaVerde

Jason Kelly, founder of the microbe engineering company Ginkgo Bioworks, wants those who work in the often-contentious field of GMOs to stand proud. After all, they’re ushering the world into the greener, cleaner future that biotechnology can create.

“We should be embracing genetic engineering and GMOs as one of the most important technologies we have available to us to improve everything — food, clothing, fragrances, medicine, really everything we make,” Kelly told the Alliance for Science.

…

Ginkgo Bioworks, which Kelly and others founded while still at MIT, is already tapping into “the ultimate technology” by designing custom microbes for a variety of clients. The Boston-based company has developed software to search DNA sequences for useful enzymes and software-directed robots to automate work previously performed laboriously by bench scientists.  As a result, it’s been able to speed up the process of producing yeast and other microbes while keeping costs down. Some 40 percent of the world’s gene printing — printing new pieces of DNA to insert into genomes — is now done at Ginkgo.

…

“Growing things is the manufacturing technology for Earth…When you think about all that amazing technology out there in nature, well, we’ve just gotten access to the code. What a gift. Now that we have the code, we can engineer what we want. All physical goods will end up being made with biology. That is the obvious endpoint of this. That’s the potential. People don’t even know it’s possible yet.”

Read full, original article: Ginkgo Bioworks: Restoring pride to GMOs

Amid activist claims Germany colluded with Big Ag to soften glyphosate regulations, Europe may switch evaluation responsibility to France

injunemoreth

Monsanto’s quest to keep its controversial weedkiller Roundup on the European market faces another challenge.

The European Commission is pushing for France — which plans to phase out Roundup’s active ingredient, glyphosate, domestically — to take over from Germany as the lead country responsible for assessing the herbicide’s safety.

The Commission’s plan, laid out in a document obtained by POLITICO, would mean that French food safety authorities would be put in charge of determining whether the weedkiller is safe for use in Europe’s agriculture sector. Their assessment would then have important influence over whether the EU decides to continue to allow glyphosate on the European market.

…

The main accusation against Germany’s food safety agency is that in its positive assessment of glyphosate, it copied dozens of pages directly from an assessment carried out by the Glyphosate Task Force, a group of 22 companies financing safety studies into the herbicide. Germany’s Federal Institute for Risk Assessment has said it “vigorously rejects” all such allegations…

…

On [July 20th] the Commission will ask member countries to discuss and potentially vote on the transfer of responsibility from Germany to France at a meeting of the Standing Committee on Plants, Animals, Food and Feed.

…

The big question now is whether France could…give more weight to…the World Health Organization’s International Agency for Research on Cancer, which stands out among global food safety authorities for its 2015 conclusion that glyphosate “is probably carcinogenic to humans.”

Read full, original article:  Brussels moves goalposts on glyphosate

New superbug? Little-known sexually transmitted disease creates worry

superbug

A little known sexually transmitted infection could become the next superbug unless people become more vigilant, experts are warning.

Mycoplasma genitalium (MG) often has no symptoms but can cause pelvic inflammatory disease, which can leave some women infertile.

…

The British Association of Sexual Health and HIV is launching new advice. Its draft guidelines detail how best to spot and treat MG.

Mycoplasma genitalium is a bacterium that can cause inflammation of the urethra in men, causing discharge from the penis and making it painful to urinate.

In women, it can cause inflammation of the reproductive organs (womb and fallopian tubes) too, causing pain and possibly a fever and some bleeding. You can get it by having unprotected sex with someone who has it. Condoms can prevent this spread.

…

Tests for MG have recently been developed but are not available in all clinics yet although doctors can send samples to Public Health England’s laboratory to get a diagnostic result.

…

Eradication rates of MG following treatment with one family of antibiotics, called macrolides, are decreasing globally. Macrolide resistance in the UK is estimated at about 40%, say the guidelines.

…

Dr Peter Greenhouse, a sexual consultant in Bristol and BASHH member, urged people to take precautions. “It’s about time the public learned about Mycoplasma genitalium,” he said.

Read full, original post: Emerging sex disease MG ‘could become next superbug’

Drugmakers accused of stalling biosimilars: FDA’s Gottlieb calls tactics ‘a toxin’

drugs

Food and Drug Administration Commissioner Scott Gottlieb on Wednesday [July 18] accused drug makers who manufacture pricey biologic medicines of using “unacceptable” anti-competitive tactics to keep competitors off the market, costing Americans billions.

The tactics — some of which Gottlieb will refer to as a “toxin” — have prevented other drug makers from launching biosimilar medicines, highly similar versions of the same drugs.

“The branded drug industry didn’t build its success by being business naïve. They are smart competitors. But that doesn’t mean we need to embrace all of these business tactics, or agree that they’re appropriate,” Gottlieb said in a speech at the Brookings Institution. “Some of these tactics should be unacceptable to every member of the drug supply chain.”

Gottlieb’s harsh remarks came as part of a preview of a new “Biosimilars Action Plan” that the administration released Wednesday. But that plan does not focus on some of the anti-competitive tactics Gottlieb criticized, since the FDA doesn’t police intellectual property disputes or rebate agreements with other parties in the supply chain.

…

It’s an attempt to help lower prices in an especially expensive category; less than 2 percent of Americans use biologic drugs, but they account for almost 40 percent of all prescription drug spending, and for 70 percent of the growth in drug spending between 2010 and 2015, as Gottlieb highlighted Wednesday.

Read full, original post: FDA’s Gottlieb slams drug makers for stalling release of biosimilars

‘War of words’ over what to call lab-grown meat exposes divide in America’s food culture

lab meat

On [July 12th], in a small but packed auditorium, the FDA convened a public meeting about lab-grown meat—but you wouldn’t have known that if you were listening for those words. According to the FDA, it was actually about “foods produced using animal-cell culture technology.”

…

Maggie Nutter of the United States Cattlemen’s Association began her four minutes of public comment by introducing herself as a fourth-generation Montana rancher who is training her children and grandchildren to be fifth- and sixth-generation ranchers. It was an appeal to tradition—to the idea of family farms and pastoral ways.

If nostalgia for traditional foodways is one pole for the current food movement, the other is environmental and social responsibility. That’s why activists have leapt from the favored scientific term cultured meat (referring to the cell cultures in which it grows) to clean meat. Clean serves many roles here: It echoes clean energy. It’s a nod to the lack of animal slaughter. And it refers to the sterile conditions under which the meat cells grow.

…

Jack Bobo, the chief communications officer of the biotech company Intrexon, favors the term craft meat over clean meat. The dinner table isn’t the place for moralizing, he told me at [the July 12th] meeting. Why not use a term that evokes craft breweries and hand-jarred pickles instead? The debate over what to call lab-grown meat is a debate over what values we deem most important in food.

Read full, original article: The Farcical Battle Over What to Call Lab-Grown Meat

Challenging the story of our origin: Human traits had ‘patchwork emergence’ across Africa

Dev UKVAAAxiKB

The origins of our species have long been traced to east Africa, where the world’s oldest undisputed Homo sapiens fossils were discovered.

…

However, a team of prominent scientists is now calling for a rewriting of this traditional narrative, based on a comprehensive survey of fossil, archaeological and genetic evidence. Instead, the international team argue, the distinctive features that make us human emerged mosaic-like across different populations spanning the entire African continent.

…

Dr Eleanor Scerri, an archaeologist at Oxford University, who led the international research, said: “This single origin, single population view has stuck in people’s mind … but the way we’ve been thinking about it is too simplistic.”

…

The telltale characteristics of a modern human – globular brain case, a chin, a more delicate brow and a small face – seem to first appear in different places at different times. Previously, this has either been explained as evidence of a single, large population trekking around the continent en masse.

…

The latest analysis suggests that this patchwork emergence of human traits can be explained by the existence of multiple populations that were periodically separated for millennia by rivers, deserts, forests and mountains before coming into contact again”

…

“Someone finds a skull somewhere and that’s the source of humanity. Someone finds some tools somewhere, that’s the source of humanity,” [Scerri] said.

Read full, original post: No single birthplace of mankind, say scientists

Despite anti-GMO ‘whispering,’ Bangladesh says ‘science-based information’ will guide its biotech policy

brinjal

Bt eggplant, or brinjal as it’s known in Bangladesh, is the first genetically engineered food crop to be successfully introduced in South Asia. Bt brinjal is helping some of the world’s poorest farmers to feed their families and communities, improve profits and dramatically reduce pesticide use.

Bt brinjal was first developed [by] scientists [who] inserted a gene from the bacterium Bacillus thuringiensis (Bt) into nine brinjal varieties. The plants were engineered to resist the fruit and shoot borer, a devastating insect whose larvae bore into the stem and fruit of an eggplant.

…

A recent survey found 50 percent of farmers in Bangladesh said that they experienced illness due to the intense spraying of insecticides.

“It’s terrible for these farmers’ health and the health of the environment to spray so much,” said [Tony] Shelton, [Cornell professor of entomology], who found that pesticide use on Bt eggplant was reduced as much as 92 percent in commercial Bt brinjal plantings. “Bt brinjal is a solution that’s really making a difference in people’s lives.”

…

In a March 2017 workshop, Bangladeshi Agriculture Minister Begum Matia Chowdhury called Bt brinjal “a success story of local and foreign collaboration.”

“We will be guided by the science-based information, not by the nonscientific whispering of a section of people,” Chowdhury said. “As human beings, it is our moral obligation that all people in our country should get food and not go to bed on an empty stomach. Biotechnology can play an important role in this effect.”

Read full, original article: Bt eggplant improving lives in Bangladesh